STAND. COM. REP. NO. 1267
RE: H.B. No. 1032
Honorable Ronald D. Kouchi
President of the Senate
Thirty-First State Legislature
Regular Session of 2021
State of Hawaii
Your Committee on Health, to which was referred H.B. No. 1032, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"
begs leave to report as follows:
The purpose and intent of this measure is to update and codify within the Uniform Controlled Substances Act, chapter 329D, Hawaii Revised Statutes, certain amendments made to the federal controlled substances law as required by section 329-11, Hawaii Revised Statutes.
Your Committee received testimony in support of this measure from the Department of Public Safety and Akamai Cannabis Clinic.
Your Committee finds that this measure is necessary to make permanent the temporary designation of new controlled substances by the Department of Public Safety, and the Department's temporary designation of the new controlled substances will be nullified if not made permanent through legislation. Your Committee also finds that existing law requires that if a substance is added, deleted, or rescheduled under federal law, or by an emergency scheduling action taken by the Department of Public Safety, then the Department is required to recommend that the Legislature make corresponding changes to Hawaii law. Your Committee further finds that the substances listed in this measure correspond to several similar changes to the Drug Enforcement Administration's federally controlled substances schedules. Thus, this measure makes consistent federal and state law.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 1032, H.D. 1, and recommends that it pass Second Reading and be referred to your Committee on Judiciary.
Respectfully submitted on behalf of the members of the Committee on Health,
JARRETT KEOHOKALOLE, Chair